Showing 1,581 - 1,600 results of 102,184 for search '(( 5 ((a decrease) OR (nn decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.74s Refine Results
  1. 1581
  2. 1582
  3. 1583

    Olig2 cells in external capsule at 48h and 5 weeks after TBI. by Krista A. Dent (709531)

    Published 2015
    “…<p>Brain sections were immunostained for Olig2 and counterstained with DAPI. Panels show (A,C) contralateral and (B,D) ipsilateral external capsule (EC) at (A,B) 48h and (C,D) 5 weeks (5wk) post-TBI. …”
  4. 1584
  5. 1585

    Table_1_Decreased Mortality Rate Among COVID-19 Patients Prescribed Statins: Data From Electronic Health Records in the US.pdf by Ivana Marić (10076962)

    Published 2021
    “…We observed a small, but statistically significant, decrease in mortality among patients prescribed statins (16.1%) when compared with matched COVID-19-positive controls (18.0 to 20.6%). …”
  6. 1586

    Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D. by Eiko Kitamura (349087)

    Published 2013
    “…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”
  7. 1587
  8. 1588
  9. 1589
  10. 1590
  11. 1591
  12. 1592
  13. 1593
  14. 1594
  15. 1595
  16. 1596

    CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

    Published 2014
    “…Values are mean±SEM, n = 4–5.</p>…”
  17. 1597
  18. 1598

    Loperamide decreases mechanical responsiveness of unmyelinated, nociceptive C-fibers. by Matthias Ringkamp (253465)

    Published 2013
    “…Dashed line indicates threshold assigned to afferents unresponsive to 25 g vF hair. B) Loperamide dose-dependently decreases the responsiveness to suprathreshold mechanical stimuli in both animal groups (ANOVA lesion: F<sub>(3,35)</sub> = 10.3, p<0.001; ANOVA sham: F<sub>(3,16)</sub> = 4.5, p<0.05). …”
  19. 1599

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
  20. 1600